Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 1788-1793, August 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grieder, A.
Right arrow Articles by Stähelin, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grieder, A.
Right arrow Articles by Stähelin, H.

Effect of an Epipodophyllotoxin Derivative (VP 16-213) on Macromolecular Synthesis and Mitosis in Mastocytoma Cells in Vitro1

Alfons Grieder, Richard Maurer and Hartmann Stähelin2

Biological and Medical Research Division, Sandoz Ltd., CH-4002 Basel, Switzerland

The influence of the semisynthetic epipodophyllotoxin derivative VP 16-213 on different cellular and biochemical parameters was determined with the use of suspension cultures of a murine mastocytoma. Cells were exponentially dividing and not synchronized. Treatment with VP 16-213 (1 µg/ml) reduced the mitotic index by more than 75% within 1.5 hr and completely prevented cell multiplication upon further incubation. DNA, RNA, and protein content per cell showed an increase upon treatment with 1 or 10 µg/ml. Thymidine incorporation, on the other hand, was reduced by 60 and 80% when P-815 cells were treated for 6.5 hr with 1 or 10 µg of the drug per ml. Incorporation of uridine and leucine into RNA and protein was enhanced with the drug (1 µg/ml), while with 10 µg/ml, uridine incorporation was reduced. These results show that precursor incorporation studies are not necessarily reflecting the synthesis of these macromolecules and suggest that VP 16-213 arrests cells in late S or G2 phase of the cell cycle.

1 A preliminary report of this work was presented at the Fifth Annual Meeting of the Swiss Society of Experimental Biology, May 1973 (7).

2 To whom reprint requests should be addressed.

Received 11/19/73. Accepted 2/ 4/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.